Leerink Partners Downgrades Bolt Biotherapeutics, Inc. (BOLT) to Market Perform 'on Uncertain Platform Outlook'
Tweet Send to a Friend
(Updated - May 15, 2024 4:32 AM EDT)Leerink Partners analyst Daina Graybosch downgraded Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
